欧美极品 欧美极品 from Houston Methodist display Latest news from Houston Methodist on 欧美极品 en-us Copyright 2024 欧美极品 欧美极品 欧美极品 from Houston Methodist 115 31 / /images/newswise-logo-rss.gif Houston Methodist Part of National Consortium to Develop Vaccine Against Herpesviruses /articles/houston-methodist-part-of-national-consortium-to-develop-vaccine-against-herpesviruses/?sc=rsin /articles/houston-methodist-part-of-national-consortium-to-develop-vaccine-against-herpesviruses/?sc=rsin Thu, 03 Oct 2024 19:05:19 EST Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government's Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects. Houston Methodist New Addition to Standard-of-Care Treatments for Non-Small-Cell Lung Cancer Patients Has Potential to Increase Progression-Free Survival /articles/new-addition-to-standard-of-care-treatments-for-non-small-cell-lung-cancer-patients-has-potential-to-increase-progression-free-survival/?sc=rsin /articles/new-addition-to-standard-of-care-treatments-for-non-small-cell-lung-cancer-patients-has-potential-to-increase-progression-free-survival/?sc=rsin Thu, 03 Oct 2024 19:05:15 EST Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common type of lung cancer. Houston Methodist Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium /articles/houston-methodist-prepares-for-next-pandemic-as-part-of-national-nih-funded-consortium/?sc=rsin /articles/houston-methodist-prepares-for-next-pandemic-as-part-of-national-nih-funded-consortium/?sc=rsin Thu, 03 Oct 2024 19:05:13 EST The question isn't if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families. Houston Methodist Houston Methodist and Rice University team up to track gut-brain connection /articles/houston-methodist-and-rice-university-team-up-to-track-gut-brain-connection/?sc=rsin /articles/houston-methodist-and-rice-university-team-up-to-track-gut-brain-connection/?sc=rsin Wed, 18 Sep 2024 16:05:47 EST For the next two years, 120 Division I Rice University athletes will be part of a concussion study with Houston Methodist researchers to identify reliable and novel concussion biomarkers in their gut microbiomes in ways that standard brain imaging cannot. Houston Methodist Neurology 'house calls' to improve quality of care and life for ALS patients /articles/neurology-house-calls-to-improve-quality-of-care-and-life-for-als-patients/?sc=rsin /articles/neurology-house-calls-to-improve-quality-of-care-and-life-for-als-patients/?sc=rsin Tue, 18 Jun 2024 14:05:59 EST When second-year neurology resident Dr. Keelie Denson asked her ALS (Amyotrophic Lateral Sclerosis) patients what they found most lacking in ALS care, the answer was easy for Angela Amar. She and her three children, now adults, had been caring for her husband Robert for more than 14 years. Houston Methodist Researchers at Houston Methodist find survival improves with open radical hysterectomy in early stage cancer /articles/researchers-at-houston-methodist-find-survival-improves-with-open-radical-hysterectomy-in-early-stage-cancer/?sc=rsin /articles/researchers-at-houston-methodist-find-survival-improves-with-open-radical-hysterectomy-in-early-stage-cancer/?sc=rsin Wed, 12 Jun 2024 13:05:14 EST Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches, according to a 5-year study led by Houston Methodist researchers and published in the Journal of Clinical Oncology. Houston Methodist Researchers at Houston Methodist find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness /articles/researchers-at-houston-methodist-find-difference-in-pancreatic-cancer-cells-offering-new-hope-for-immunotherapy-effectiveness/?sc=rsin /articles/researchers-at-houston-methodist-find-difference-in-pancreatic-cancer-cells-offering-new-hope-for-immunotherapy-effectiveness/?sc=rsin Tue, 30 Apr 2024 17:05:20 EST A team led by a Houston Methodist physician established a hypothesis that the microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy receptors found on each section of the pancreas, differ. This could impact the way cancer of the pancreas is treated. Houston Methodist Researchers look at how pollution, weather, noise, social factors impact AFib /articles/researchers-look-at-how-pollution-weather-noise-social-factors-impact-afib/?sc=rsin /articles/researchers-look-at-how-pollution-weather-noise-social-factors-impact-afib/?sc=rsin Thu, 18 Apr 2024 09:05:24 EST Houston Methodist King Charles was treated for a prostate condition that impacts nearly half of men over the age of 50. Dr. Richardo Gonzalez, an internationally recognized expert in therapies for BPH, is available for interviews /articles/king-charles-was-treated-for-a-prostate-condition-that-impacts-nearly-half-of-men-over-the-age-of-50-dr-richardo-gonzalez-an-internationally-recognized-expert-in-therapies-for-bph-at-houston-methodist-hospital-is-available-to-discuss-the-most-common-and-m/?sc=rsin /articles/king-charles-was-treated-for-a-prostate-condition-that-impacts-nearly-half-of-men-over-the-age-of-50-dr-richardo-gonzalez-an-internationally-recognized-expert-in-therapies-for-bph-at-houston-methodist-hospital-is-available-to-discuss-the-most-common-and-m/?sc=rsin Tue, 23 Jan 2024 09:30:58 EST Houston Methodist Medicine & Magic: Parallel Pathways and Similar Goals /articles/medicine-magic-parallel-pathways-and-similar-goals/?sc=rsin /articles/medicine-magic-parallel-pathways-and-similar-goals/?sc=rsin Fri, 27 Oct 2023 11:55:30 EST Houston Methodist Director of Houston Methodist Concussion Center available to comment on JAMA study of 152 brain donors under 30 who were exposed to repetitive head impacts from contact sports /articles/director-of-houston-methodist-concussion-center-available-to-comment-on-jama-study-of-152-brain-donors-under-20-who-were-exposed-to-repetitive-head-impacts-from-contact-sports/?sc=rsin /articles/director-of-houston-methodist-concussion-center-available-to-comment-on-jama-study-of-152-brain-donors-under-20-who-were-exposed-to-repetitive-head-impacts-from-contact-sports/?sc=rsin Thu, 07 Sep 2023 10:05:55 EST Houston Methodist Using AI to Speed Up Vaccine Development Against Disease X /articles/using-ai-to-speed-up-vaccine-development-against-disease-x/?sc=rsin /articles/using-ai-to-speed-up-vaccine-development-against-disease-x/?sc=rsin Tue, 18 Jul 2023 09:00:53 EST CEPI to provide up to $4.98 USD million to Houston Methodist Research Institute-led consortium to use artificial intelligence for design of vaccines to fight diseases with pandemic potential. The project will support a consortium, led by HMRI, to design potential antigenic targets for up to 10 priority virus families with epidemic or pandemic potential. Laboratory-based tests will then be used to verify antigen designs for possible further development. Houston Methodist New analysis shows COVID variant and severity of illness influence cardiac dysfunction, a key indicator of long COVID /articles/new-analysis-shows-covid-variant-and-severity-of-illness-influence-cardiac-dysfunction-a-key-indicator-of-long-covid/?sc=rsin /articles/new-analysis-shows-covid-variant-and-severity-of-illness-influence-cardiac-dysfunction-a-key-indicator-of-long-covid/?sc=rsin Mon, 05 Jun 2023 12:05:30 EST Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID, according to a recent study published in the European Heart Journal - Cardiovascular Imaging. Patients recovering from the omicron variant were least likely to have microvascular involvement. The study also found that microvascular dysfunction started to be seen less often after nine months to one year following infection suggesting that this type of abnormality may be reversible. Houston Methodist Houston Methodist Hospital reaches 10,000 transplant milestone /articles/houston-methodist-hospital-reaches-10-000-transplant-milestone/?sc=rsin /articles/houston-methodist-hospital-reaches-10-000-transplant-milestone/?sc=rsin Fri, 05 May 2023 14:35:55 EST Surgeons at Houston Methodist Hospital successfully completed its 10,000th organ transplant yesterday. Houston Methodist Study suggests longer time between COVID-19 vaccines more effective for some /articles/study-suggests-longer-time-between-covid-19-vaccines-more-effective-for-some/?sc=rsin /articles/study-suggests-longer-time-between-covid-19-vaccines-more-effective-for-some/?sc=rsin Tue, 18 Apr 2023 19:20:44 EST A recent Houston Methodist study may offer some guidance on when certain populations should get their next booster. A research team of computational medicine and data scientists from the Houston Methodist Research Institute predicted the immune response to COVID-19 vaccines with a math model they developed, and also found that current CDC dosing intervals may require customization to protect all individuals alike. Houston Methodist Implantable device shrinks pancreatic tumors /articles/implantable-device-shrinks-pancreatic-tumors/?sc=rsin /articles/implantable-device-shrinks-pancreatic-tumors/?sc=rsin Thu, 13 Apr 2023 14:35:43 EST Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of rice. Houston Methodist Researchers discover way to reverse infertility by reducing HDL cholesterol /articles/researchers-discover-way-to-reverse-infertility-by-reducing-hdl-cholesterol/?sc=rsin /articles/researchers-discover-way-to-reverse-infertility-by-reducing-hdl-cholesterol/?sc=rsin Thu, 16 Mar 2023 17:05:36 EST Houston Methodist scientists reversed infertility in sterile mice by reducing HDL cholesterol with a bacterial protein in a promising development that shows further evidence linking high cholesterol to female infertility. The researchers worked with a protein called serum opacity factor that lowered cholesterol levels by over 40% in three hours. Houston Methodist Surgeons Remove Grapefruit-Sized Tumor From Man's Brain; Implant 3D Computer Generated Prosthetic Skull Piece /articles/surgeons-remove-grapefruit-sized-tumor-from-man-s-brain-implant-3d-computer-generated-prosthetic-skull-piece/?sc=rsin /articles/surgeons-remove-grapefruit-sized-tumor-from-man-s-brain-implant-3d-computer-generated-prosthetic-skull-piece/?sc=rsin Thu, 27 Oct 2022 15:30:27 EST Patient Chris DeHart had a massive meningioma that required 9 surgeries and 3 surgical specialties to remove. He relied on a Houston Methodist 'dream team' of surgeons to solve his case. Houston Methodist Small Test Group Shows ALS Patients' Own Cells May Provide a Safe Pathway to Slow or Halt Progression of the Deadly Degenerative Disease /articles/small-test-group-shows-als-patients-own-cells-may-provide-a-safe-pathway-to-slow-or-halt-progression-of-the-deadly-degenerative-disease/?sc=rsin /articles/small-test-group-shows-als-patients-own-cells-may-provide-a-safe-pathway-to-slow-or-halt-progression-of-the-deadly-degenerative-disease/?sc=rsin Wed, 05 Oct 2022 16:15:07 EST Removing ALS (amyotrophic lateral sclerosis) patients' own dysfunctional cells, fixing them, then putting them back in patients' bodies is a safe, well tolerated process that has been shown to slow or halt disease progression in a small number of patients, according to a study by the Houston Methodist Research Institute and Massachusetts General Hospital Houston Methodist Houston Methodist enters the metaverse with launch of new MITIEverse(tm) app /articles/houston-methodist-enters-the-metaverse-with-launch-of-new-mitieverse-app/?sc=rsin /articles/houston-methodist-enters-the-metaverse-with-launch-of-new-mitieverse-app/?sc=rsin Tue, 04 Oct 2022 10:05:15 EST Exploring the heart from the inside out is now possible with a new app from Houston Methodist. Houston Methodist